Diazepam withdrawal-induced anxiety and place aversion in the rat: differential effects of two chronic diazepam treatment regimes

被引:10
作者
Allison, C [1 ]
Claase, LA [1 ]
Pratt, JA [1 ]
机构
[1] Univ Strathclyde, Dept Physiol & Pharmacol, Strathclyde Inst Biomed Sci, Glasgow G4 0NR, Lanark, Scotland
来源
BEHAVIOURAL PHARMACOLOGY | 2002年 / 13卷 / 5-6期
关键词
benzodiazepine; withdrawal; precipitated withdrawal; conditioned place aversion; flumazenil; pharmacokinetic; elevated plus-maze; rat;
D O I
10.1097/00008877-200209000-00015
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The ability of the benzodiazepine antagonist flumazenil to precipitate a withdrawal subjective state in rats receiving chronic diazepam was investigated in a biased conditioned place aversion (CPA) procedure. Conditioning with flumazenil (10 mg/kg i.p.) in rats receiving chronic diazepam subcutaneously (s.c. in oil, 15 mg/kg/day for 28 days) but not intraperitoneally (i.p., 5 mg/kg for 28 days) resulted in the formation of a conditioned place aversion. These results indicate that precipitated withdrawal from diazepam injected s.c. but not i.p. produces a negative subjective state and that the conditioned place aversion paradigm may be useful in detecting the negative subjective effects of diazepam withdrawal. In parallel studies, the same s.c. treatment protocol produced an anxiogenic effect in the elevated plus-maze on spontaneous diazepam withdrawal, whereas rats treated with the i.p. protocol displayed no signs of withdrawal anxiety. The results of the present study are consistent with the interpretation that rats withdrawn from chronic i.p. diazepam did not demonstrate a CPA due to the 'repeated withdrawal' experiences induced by the i.p. injection route attenuating the subsequent ability of flumazenil to precipitate a subjective withdrawal state. Pharmacokinetic evidence and previous evidence showing that repeated withdrawal from diazepam in mice attenuates the aversive effects of the withdrawal experience in a conditioned taste aversion (CTA) paradigm support this interpretation. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:417 / 425
页数:9
相关论文
共 32 条
[1]   The biological, social and clinical bases of drug addiction: Commentary and debate [J].
Altman, J ;
Everitt, BJ ;
Glautier, S ;
Markou, A ;
Nutt, D ;
Oretti, R ;
Phillips, GD ;
Robbins, TW .
PSYCHOPHARMACOLOGY, 1996, 125 (04) :285-345
[2]   GABAA receptor gene expression in rat cortex:: Differential effects of two chronic diazepam treatment regimes [J].
Arnot, MI ;
Davies, M ;
Martin, IL ;
Bateson, AN .
JOURNAL OF NEUROSCIENCE RESEARCH, 2001, 64 (06) :617-625
[3]   NEUROBIOLOGY OF WITHDRAWAL MOTIVATION - EVIDENCE FOR 2 SEPARATE AVERSIVE EFFECTS PRODUCED IN MORPHINE-NAIVE VERSUS MORPHINE-DEPENDENT RATS BY BOTH NALOXONE AND SPONTANEOUS WITHDRAWAL [J].
BECHARA, A ;
NADER, K ;
VANDERKOOY, D .
BEHAVIORAL NEUROSCIENCE, 1995, 109 (01) :91-105
[4]   USE OF THE SPECIFIC BENZODIAZEPINE ANTAGONIST, RO 15-1788, IN STUDIES OF PHYSIOLOGICAL DEPENDENCE ON BENZODIAZEPINES [J].
CUMIN, R ;
BONETTI, EP ;
SCHERSCHLICHT, R ;
HAEFELY, WE .
EXPERIENTIA, 1982, 38 (07) :833-834
[5]   CONDITIONED PLACE PREFERENCE INDUCED BY RO-16-6028, A BENZODIAZEPINE RECEPTOR PARTIAL AGONIST [J].
DISCALA, G ;
OBERLING, P ;
ROCHA, B ;
SANDNER, G .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1992, 41 (04) :859-862
[6]   Previous experience of withdrawal from chronic diazepam ameliorates the aversiveness of precipitated withdrawal and reduces withdrawal-induced c-fos expression in nucleus accumbens [J].
Dunworth, SJ ;
Mead, AN ;
Stephens, DN .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (04) :1501-1508
[7]   ANXIOGENIC ASPECTS OF DIAZEPAM WITHDRAWAL CAN BE DETECTED IN ANIMALS [J].
EMMETTOGLESBY, M ;
SPENCER, D ;
LEWIS, M ;
ELMESALLAMY, F ;
LAL, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 92 (1-2) :127-130
[8]  
EMMETTOGLESBY MW, 1988, J PHARMACOL EXP THER, V244, P892
[9]   The effect of treatment regimen on the development of tolerance to the sedative and anxiolytic effects of diazepam [J].
Fernandes, C ;
Arnot, MI ;
Irvine, EE ;
Bateson, AN ;
Martin, IL ;
File, SE .
PSYCHOPHARMACOLOGY, 1999, 145 (03) :251-259
[10]  
FILE S E, 1989, Human Psychopharmacology, V4, P59